337 related articles for article (PubMed ID: 27085747)
21. Screening for prostate cancer: time to put all the data on the table.
Haines IE; Ablin RJ; Miklos GL
BMJ; 2016 May; 353():i2574. PubMed ID: 27226459
[No Abstract] [Full Text] [Related]
22. PSA screening: the USPSTF got it wrong.
Scherger JE
J Fam Pract; 2013 Nov; 62(11):616, 618. PubMed ID: 24288701
[No Abstract] [Full Text] [Related]
23. New PSA guidelines discourage overscreening.
Peres J
J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
[No Abstract] [Full Text] [Related]
24. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
Zargar H; van den Bergh R; Moon D; Lawrentschuk N; Costello A; Murphy D
BJU Int; 2017 Jan; 119(1):110-115. PubMed ID: 27454454
[TBL] [Abstract][Full Text] [Related]
25. Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer.
Pini G; Collins J; Ghadjar P; Wiklund P
Curr Urol Rep; 2015 May; 16(5):28. PubMed ID: 25773347
[TBL] [Abstract][Full Text] [Related]
26. Screening for prostate cancer: prostate-specific antigen testing is not effective.
Hitzeman N; Molina M
Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
[No Abstract] [Full Text] [Related]
27. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
Jackson BR
Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
[No Abstract] [Full Text] [Related]
28. Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.
Carlsson SV; de Carvalho TM; Roobol MJ; Hugosson J; Auvinen A; Kwiatkowski M; Villers A; Zappa M; Nelen V; Páez A; Eastham JA; Lilja H; de Koning HJ; Vickers AJ; Heijnsdijk EA
Cancer; 2016 Nov; 122(21):3386-3393. PubMed ID: 27459245
[TBL] [Abstract][Full Text] [Related]
29. States renewing attention to prostate cancer.
Rossiter C
NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
[No Abstract] [Full Text] [Related]
30. Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates.
Bhindi B; Mamdani M; Kulkarni GS; Finelli A; Hamilton RJ; Trachtenberg J; Zlotta AR; Evans A; van der Kwast TH; Toi A; Fleshner NE
J Urol; 2015 May; 193(5):1519-24. PubMed ID: 25481037
[TBL] [Abstract][Full Text] [Related]
31. The pendulum swings back: Screening for prostate cancer in 2018.
Thompson IM
Cancer; 2018 Jul; 124(13):2690-2692. PubMed ID: 29786846
[No Abstract] [Full Text] [Related]
32. Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations.
Rahbar H; Karabon P; Menon M; Trinh QD; Abdollah F
Eur Urol Focus; 2018 Dec; 4(6):1002-1004. PubMed ID: 28753856
[TBL] [Abstract][Full Text] [Related]
33. [CONs].
Sobue T
Gan To Kagaku Ryoho; 2014 May; 41(5):553-7. PubMed ID: 24917002
[TBL] [Abstract][Full Text] [Related]
34. Liaise with pathologists to refine understanding of the prostate-specific antigen test.
Sikaris KA; Ross BA; Khong TY
Med J Aust; 2013 Nov; 199(10):656, 658. PubMed ID: 24237087
[No Abstract] [Full Text] [Related]
35. US expert panel recommends against prostate cancer screening.
Lenzer J; Brownlee S
BMJ; 2011 Oct; 343():d6479. PubMed ID: 21987717
[No Abstract] [Full Text] [Related]
36. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.
Crawford ED; Rosenberg MT; Partin AW; Cooperberg MR; Maccini M; Loeb S; Pettaway CA; Shore ND; Arangua P; Hoenemeyer J; Leveridge M; Leapman M; Pinto P; Thompson IM; Carroll P; Eastham J; Gomella L; Klein EA
Urology; 2016 Oct; 96():116-120. PubMed ID: 27450937
[No Abstract] [Full Text] [Related]
37. Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.
Wilt TJ; Scardino PT; Carlsson SV; Basch E
J Natl Cancer Inst; 2014 Mar; 106(3):dju010. PubMed ID: 24594482
[No Abstract] [Full Text] [Related]
38. Screening for prostate cancer.
Stewart RW; Lizama S; Peairs K; Sateia HF; Choi Y
Semin Oncol; 2017 Feb; 44(1):47-56. PubMed ID: 28395763
[TBL] [Abstract][Full Text] [Related]
39. Editorial: Prostate cancer screening: perhaps a little patience is the answer.
Jarrett TW
Can J Urol; 2012 Oct; 19(5):6409. PubMed ID: 23040616
[No Abstract] [Full Text] [Related]
40. Reconsidering Prostate Cancer Screening.
Schmidt C
J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
